TrialPloS one2015

Prospective immune dynamics during the first 24 weeks of efavirenz based-antiretroviral therapy in HIV-1-infected subjects, according to CD4+ T-cell counts at presentation: the IMMUNEF clinical trial.

Alessandro Soria et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.